98%
921
2 minutes
20
Left atrial appendage occlusion (LAAO) is an emerging treatment option for cardioembolic stroke risk reduction in patients with sustained or paroxysmal atrial fibrillation (AF). How LAAO affects the atrial blood flow field during sinus rhythm has not yet been defined. Here, we simulated virtual LAAO in 21 paroxysmal AF patients and eight controls in normal sinus rhythm using computational fluid dynamics (CFD). We found that in AF patients, LAAO reduces the amount of blood that remains in the LA for more than three cardiac cycles to levels similar to the control group with intact LAA. However, there is a large variation among the AF group and even after LAAO the patients with highest stasis still had a relatively large amount of blood remaining in the LA over multiple cycles. This remaining blood is predominately located close to the site of LAA occlusion, a region where occlusion device related thrombi are known to occur. Accurate patient stratification is important to identify the impacts of LAAO on the patient specific haemodynamics. KEY POINTS: Patients with atrial fibrillation (AF) have an increased risk for stroke. One underlying mechanism for this is that thrombi form in the left atrial appendage (LAA). To reduce the risk of thrombi forming in the LAA, it can be closed with an occlusion device. In this study, we simulated how the blood flows in the left atrium of AF patients before and after a virtual LAA occlusion and compared it to a control group. We found that LAA occlusion could reduce the time blood stays in the left atrium in most patients with AF to similar levels as the control group. But in some patients, blood stagnated for a long time even after LAA occlusion. Our results help us understand why thrombi can form even after LAA occlusion and might help to predict which patients could benefit most from LAA occlusion.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1113/JP288587 | DOI Listing |
JACC Cardiovasc Imaging
September 2025
Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Electronic address:
Background: Residual leaks are common after left atrial appendage occlusion (LAAO).
Objectives: The authors aimed to systematically evaluate the prognostic implications of residual left atrial appendage (LAA) patency and peridevice leaks (PDLs) detected by cardiac computed tomography (CT) following LAAO.
Methods: The authors used traditional meta-analytical methods and a Bayesian framework to assess the probability of increased risks associated with these residual leaks.
Struct Heart
August 2025
Section on Cardiology, Atrium Health Wake Forest Baptist Medical Center, Winston Salem, North Carolina, USA.
Background: Mounting evidence suggests surgical left atrial appendage (LAA) exclusion reduces stroke risk in patients with atrial fibrillation. Prior older research suggests that LAA exclusion is often incomplete, but few transesophageal echocardiogram (TEE) data exist evaluating LAA remnants.
Methods: We analyzed 121 patients with an available postoperative TEE who underwent LAA exclusion by surgical excision (SE), AtriClip occlusion (AO), or Tiger Paw occlusion (TO).
Circ Arrhythm Electrophysiol
August 2025
Texas Cardiac Arrhythmia Institute, St David's Medical Center, Austin, TX (V.M.L.F., S.M., C.G., E.Z., N.P., P.G.T., W.B., J.D.B., R.H., A.A.-A., L.D.B., A.N.).
Background: The safety and efficacy of pulsed field ablation for pulmonary vein and posterior wall isolation in atrial fibrillation ablation are well established; however, evidence regarding its use in extra-pulmonary vein areas remains limited. The aim of this study was to assess the feasibility and durability of pulsed field ablation for coronary sinus (CS) and left atrial appendage (LAA) isolation and mitral isthmus (MI) ablation.
Methods: We analyzed data from consecutive patients who underwent repeat atrial fibrillation ablation with pulsed field ablation between February and October 2024.
Neurol Int
August 2025
Department of Radiology and Neuroradiology, University Medical Center Schleswig-Holstein, Campus Kiel, 24103 Kiel, Germany.
Large vessel occlusion (LVO) strokes account for a significant proportion of ischemic strokes and are often cardioembolic in origin, particularly following atrial fibrillation (AF) with thrombus formation in the left atrial appendage (LAA). Although direct oral anticoagulation (DOAC) therapy reduces stroke risk in AF, anatomical and flow-related factors may still allow thrombi to form and persist, revealing the limitations of anticoagulation in high-risk patients. Examining structural and hemodynamic factors contributing to thrombus persistence is essential for optimizing patient management.
View Article and Find Full Text PDFEur Heart J Case Rep
August 2025
Department of Rhythmology, Cardiology and Internal Medicine, Asklepios Klinik Altona, Paul-Ehrlich-Straße 1, Hamburg 22763, Germany.
Background: Pulsed field ablation (PFA) is a novel non-thermal cardiac ablation method utilizing irreversible electroporation which has been introduced especially for treatment of atrial fibrillation (AF) by pulmonary vein isolation (PVI). Interventional left atrial appendage closure (LAAC) is an alternative to oral anticoagulation (OAC) in patients with non-valvular AF and high stroke risk who are ineligible for OAC. A concomitant PVI and LAAC might be beneficial for patients.
View Article and Find Full Text PDF